Connection

JESUS VALLEJO to Lipopolysaccharides

This is a "connection" page, showing publications JESUS VALLEJO has written about Lipopolysaccharides.
Connection Strength

0.309
  1. Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes. Drug Metab Dispos. 2011 May; 39(5):874-81.
    View in: PubMed
    Score: 0.081
  2. Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. Tex Heart Inst J. 2008; 35(1):16-21.
    View in: PubMed
    Score: 0.066
  3. CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation. 2002 Nov 12; 106(20):2608-15.
    View in: PubMed
    Score: 0.046
  4. Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol. 2002 Jun; 282(6):H2316-23.
    View in: PubMed
    Score: 0.045
  5. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J Infect Dis. 2001 Jun 01; 183(11):1617-24.
    View in: PubMed
    Score: 0.041
  6. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J Infect Dis. 1996 Aug; 174(2):332-7.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.